2 results match your criteria: "Icahn School of Medicine at Mount Sinai The Mount Sinai Medical Center[Affiliation]"
Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation.
JACC Clin Electrophysiol
May 2024
Department of Cardiothoracic Surgery, University of Brescia, Brescia, Italy.
Background: Postoperative atrial fibrillation (POAF) is associated with increased morbidity and mortality. Epicardial injection of botulinum toxin may suppress POAF.
Objectives: This study sought to assess the safety and efficacy of AGN-151607 for the prevention of POAF after cardiac surgery.
The Epidemiology, Pathophysiology, and Novel Treatment of Calcific Arterial Disease.
Surg Technol Int
May 2019
Division of Vascular Surgery, Icahn School of Medicine at Mount Sinai The Mount Sinai Medical Center, New York, New York.
Article Synopsis
- Endovascular treatment for arterial diseases is now preferred due to advancements in technology, but calcified lesions have complicated procedures like EVAR and TAVR.
- The Peripheral Intravascular Lithotripsy (IVL) System uses mechanical energy to break up calcified arteries, making procedures easier and safer.
- The paper discusses successful case applications of IVL, showing its potential benefits in improving artery access and treatment outcomes.